SRXH — SRX Global Inc.

—
NYSE · Consumer Staples · Food Products · CIK 1471727 ·
Last close
$0.89
Market Cap
$17.98M
52W High
$41.55
52W Low
$0.71
ADV30
498,812
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 3,392,000 904,000 -3,201,000 -4,140,000 145,357,000 35,186,000 2,368,000
Mar 2026 3,439,000 1,275,000 -1,818,000 -6,381,000 43,364,000 20,543,000 25,078,000
Dec 2025 2,807,000 1,054,000 -3,790,000 -8,614,000 27,053,000 13,060,000 23,529,000
Sep 2025 -34,548,000 -8,770,000 18,081,000 -15,261,000 8,402,000 1,309,000 7,995,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-2,904,000
Investing CF
$-31,563,000
Financing CF
$79,087,000
CapEx
$-8,467,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-51.19
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-42,063,000
Inventory
$2,611,000
Receivables
$8,569,000
ST Investments
$13,002,000
EBIT TTM
$5,984,000
Pretax Income TTM
$2,607,000
Interest Exp TTM
$3,637,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,780,000
EBITDA
$-15,468,000
Free Cash Flow
—
Enterprise Value
$-13,993,957
Total Cash
$48,188,000
Total Debt
$0
Shares Out
20,265,391
Trailing EPS
$-132.34
Book Value
$3.29
ROE
—
ROA
—
Div Yield
—

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Sep 2025 6,534,000 -11,406,000 -45,006,000 8,402,000 7,995,000 407,000 -8,143,000
Sep 2024 0 0 -43,054,000 33,764,000 88,883,000 -55,119,000 -1,478,000

TTM Snapshot

Revenues TTM
$-13,806,000
NetIncome TTM
$-49,570,000
OpCashFlow TTM
—
Assets (Latest)
$145,357,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
MDWK MDWerks, Inc. $17.10M $0.07 —
BSFC Blue Star Foods Corp. $19.59M $0.11 —
BRLS Borealis Foods Inc. $21.03M $0.98 —
MTTCF Steakholder Foods Ltd. $22.72M $0.00 —
WVVIP WILLAMETTE VALLEY VINEYARDS INC $14.15M $2.85 —

News headlines (Yahoo Finance, 1h cache)

SRX Global Provides Update on Balance Sheet and Share Buyback
2026-10-30 19:16 · Yahoo
SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies
2026-10-26 13:05 · Yahoo
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
2026-10-08 12:35 · Yahoo
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancie
2026-10-07 19:00 · Yahoo
SRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
2026-10-06 20:20 · Yahoo
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
2026-09-24 16:30 · Yahoo
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
2026-09-23 20:05 · Yahoo
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
2026-09-03 12:15 · Yahoo
SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
2026-08-31 11:30 · Yahoo
SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ...
2026-08-14 05:02 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.